Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Endotoxin Research|January 23, 2003
Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitisBernd Echtenacher, Daniela N Männel
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 24, 2003
TNF-independent development of transient anemia of chronic disease in a mouse model of protracted septic peritonitisThomas Schubert, Bernd Echtenacher, Ferdinand Hofstädter, et al.
Infection and Immunity|July 26, 2005
Divergence of protection induced by bacterial products and sepsis-induced immune suppressionTheo Sterns, Nils Pollak, Bernd Echtenacher, et al.
International Journal of Molecular Medicine|September 6, 2005
Failure of interferon-gamma and tumor necrosis factor in mediating anemia of chronic disease in a mouse model of protracted septic peritonitisThomas E O Schubert, Bernd Echtenacher, Ferdinand Hofstädter, et al.
Immunobiology|January 30, 2004
Treatment of experimental sepsis-induced immunoparalysis with TNFBernd Echtenacher, Renate Urbaschek, Karin Weigl, et al.
International Journal of Medical Microbiology : IJMM|May 11, 2010
AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatusFranziska Dirr, Bernd Echtenacher, Jürgen Heesemann, et al.
Immunity, Inflammation and Disease|January 7, 2016
TNF and regulatory T cells are critical for sepsis-induced suppression of T cellsDavid Stieglitz, Tobias Schmid, Nirav F Chhabra, et al.
International Journal of Medical Microbiology : IJMM|May 24, 2011
Studies on galactofuranose-containing glycostructures of the pathogenic mold Aspergillus fumigatusLeonie Heesemann, Andrea Kotz, Bernd Echtenacher, et al.
Infection and Immunity|August 24, 2004
Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitisMichaela Windbichler, Bernd Echtenacher, Thomas Hehlgans, et al.
Pageof 3